Table: Fuji Pharmaceutical - 9-MTH group results

Fuji Pharma

08/08/2023 09:00

Aug 8 (Reuters)- 
             Fuji Pharmaceutical  Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Jun 30, 2023        Jun 30, 2022     Sep 30, 2023 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             29.48               26.47            43.31    
                 (+11.4 pct)         (+3.8 pct)       (+22.3 pct) 
  Operating          2.40                3.61             4.05    
                 (-33.5 pct)         (+0.3 pct)       (+7.2 pct)  
  Recurring          2.74                3.83             4.09    
                 (-28.4 pct)         (+6.2 pct)       (+9.7 pct)  
  Net                1.98                2.64             2.97    
                 (-25.0 pct)         (+0.0 pct)       (+10.3 pct) 
  EPS             81.58 yen          108.77 yen       122.42 yen  
  Ann Div                             35.00 yen        37.00 yen  
  -Q2 div         17.00 yen           15.00 yen                   
  -Q4 div                             20.00 yen        20.00 yen  
  
  NOTE - Fuji Pharmaceutical  Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4554.T